Ambeed.cn

首页 / 天然产物 / 菊科 / 苍术属

货号 产品名 纯度
A132263 现货 Atractyloside A/苍术苷 A

Atractyloside A is a natural TCM reference compound.

99%+
A506949 现货 Atractylenolide I/白术内酯 I

Atractylenolide I, a natural compound extracted from largehead atractylodes rhizome, induces apoptosis and brings about cytotoxicity of human promyeloleukemic HL-60 cells. It is also a TLR4-antagonizing agent.

99%
A191904 现货 Atractylenolide II/苍术内酯 II

Atractylenolide II is a sesquiterpene compound isolated from the dried rhizome of Atractylodes macrocephala (Baizhu in Chinese) with anti-proliferative activity.

98+%
A907987 现货 Atractylenolide III/白术内酯 III

Atractylenolide III, a natural product isolated and purified from the rhizome of Atractylodes macrocephala Koidz., may have therapeutic potential in treating homocysteine-mediated cognitive impairment and neuronal injury, and is a potential candidate for treatment of human lung carcinoma by inducing the release of cytochrome c, upregulating the expression of bax and translocating apoptosis-inducing factor.

98%
A138955 现货 Atractylodin/苍术素

Atractylodin is an active component of the essential oil contained in the rhizomes of Atractylodes lancea and A.

98%
A615649 现货 Beta-Eudesmol/β-桉叶醇

Beta-Eudesmol is a natural oxygenated sesquiterpene, activates hTRPA1, with an EC50 of 32.5 μM. Beta-Eudesmol increases appetite through TRPA1[1].

98%
A230303 现货 Atractyloside potassium salt/苍术苷钾盐

Atractyloside is a natural compound that acts both an inhibitor of ANT and an apoptosis inducer.

95%
A1337805 Mucrolidin

99+%
A1984246 Atractylochromene

98%
A1671569 (1,5E,11E)-Tridecatriene-7,9-diyne-3,4-diacetate

98%
A1164201 Eudesmol/桉叶醇

A1365727 Acetylatractylodinol

98%
A2792825 Atractylenolide II/苍术内酯 II

99+%
A2792949 Atractylenolide III/白术内酯 III

99%
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。